| NCT01303406 | Friedreich's Ataxia | Drug: Idebenone|Drug: Placebo | Santhera Pharmaceuticals | Phase 3 | 2011-04-01 | 2016-02-10 |
| NCT00229632 | Friedreich Ataxia | Drug: Idebenone | National Institute of Neurological Disorders and Stroke (NINDS)|National Institutes of Health Clinical Center (CC) | Phase 2 | 2005-09-23 | 2017-01-24 |
| NCT00697073 | Friedreich's Ataxia | Drug: Idebenone | Santhera Pharmaceuticals | Phase 3 | 2008-07-01 | 2013-05-24 |
| NCT00758225 | Duchenne Muscular Dystrophy | Drug: Idebenone | Santhera Pharmaceuticals | Phase 2 | 2008-09-01 | 2011-05-30 |
| NCT01027884 | Muscular Dystrophy, Duchenne|Ambulatory Care | Drug: Placebo|Drug: Idebenone | Santhera Pharmaceuticals | Phase 3 | 2009-07-01 | 2015-09-23 |
| NCT00950248 | Primary Progressive Multiple Sclerosis | Drug: Idebenone | National Institute of Neurological Disorders and Stroke (NINDS)|National Institutes of Health Clinical Center (CC) | Phase 1|Phase 2 | 2009-07-20 | 2017-01-24 |
| NCT00905268 | Friedreich's Ataxia | Drug: idebenone|Drug: Placebo | Santhera Pharmaceuticals | Phase 3 | 2006-04-01 | 2016-05-19 |
| NCT00747487 | Leber's Hereditary Optic Neuropathy | Drug: Idebenone|Drug: Placebo | Santhera Pharmaceuticals | Phase 2 | 2007-11-01 | 2013-05-24 |
| NCT00537680 | Friedreich's Ataxia | Drug: Idebenone|Drug: Idebenone|Drug: Placebo | Santhera Pharmaceuticals | Phase 3 | 2007-12-01 | 2012-02-02 |
| NCT00993967 | Freidreich's Ataxia | Drug: idebenone | Santhera Pharmaceuticals | Phase 3 | 2007-06-01 | 2012-08-28 |
| NCT00887562 | MELAS Syndrome | Drug: Idebenone|Drug: Idebenone|Other: Placebo | Michio Hirano|Santhera Pharmaceuticals|Columbia University | Phase 2 | 2009-05-01 | 2016-09-20 |
| NCT02814019 | Duchenne Muscular Dystrophy (DMD) | Drug: Idebenone 150 mg film-coated tablets|Drug: placebo | Santhera Pharmaceuticals | Phase 3 | 2016-09-01 | 2017-03-17 |
| NCT01854359 | Multiple Sclerosis|Primary Progressive Multiple Sclerosis | Drug: Idebenone | National Institute of Neurological Disorders and Stroke (NINDS)|National Institutes of Health Clinical Center (CC) | Phase 1|Phase 2 | 2013-02-22 | 2017-01-24 |
| NCT00654784 | Duchenne Muscular Dystrophy (DMD) | Drug: idebenone|Drug: placebo | Santhera Pharmaceuticals | Phase 2 | 2005-10-01 | 2011-07-29 |
| NCT00078481 | Friedreich Ataxia | Drug: Idebenone | National Institute of Neurological Disorders and Stroke (NINDS)|National Institutes of Health Clinical Center (CC) | Phase 1 | 2004-02-01 | 2008-03-03 |
| NCT00015808 | Friedreich Ataxia | Drug: Idebenone | National Institute of Neurological Disorders and Stroke (NINDS)|National Institutes of Health Clinical Center (CC) | Phase 1 | 2001-05-01 | 2006-07-11 |
| NCT01495715 | Leber's Hereditary Optic Neuropathy | Drug: Idebenone|Drug: Placebo | Santhera Pharmaceuticals | Phase 3 | null | 2014-08-21 |
| NCT02887443 | Drug-Drug Interaction | Drug: Raxone (idebenone 150 mg)|Drug: Midazolam 2,5 mg | Santhera Pharmaceuticals | Phase 1 | 2016-09-01 | 2016-11-23 |
| NCT02774005 | Leber's Hereditary Optic Neuropathy (LHON) | Drug: Idebenone | Santhera Pharmaceuticals | Phase 4 | 2016-05-01 | 2017-03-01 |
| NCT02771379 | Leber's Hereditary Optic Neuropathy (LHON) | Drug: Idebenone | Santhera Pharmaceuticals | | 2016-09-01 | 2017-03-01 |
| NCT01421381 | Leber's Hereditary Optic Neuropathy | | Santhera Pharmaceuticals | | 2011-09-01 | 2013-05-24 |
| NCT00224640 | Friedreich Ataxia | Drug: Iron chelating intervention | Assistance Publique - H么pitaux de Paris | Phase 1|Phase 2 | 2005-03-01 | 2009-03-03 |
| NCT03014908 | Type1diabetes | Other: Blood sampling | Hasselt University|Jessa Hospital | | 2014-01-01 | 2017-01-06 |
| NCT03014856 | Obesity, Pediatric | Other: Blood sampling | Hasselt University|Jessa Hospital | | 2012-05-01 | 2017-01-05 |
